SpaceX Launchpad's total subscription allocation has expanded to 7 million USDT, equivalent to 53,800 SPACE(PRE). The subscription price is set at 130 USDT
BNP PARIBAS PRESENTS THE GROWTH STRATEGY OF ITS COMMERCIAL BANK IN BELGIUM (CPBB) AND RAISES ITS PROFITABILITY TARGETS TO 22% PRE-TAX RONE IN 2028 AND 25% IN 2030
MEXC SPACEX(PRE) Launchpad is with total subscriptions surpassing $56 million and the most competitive pool reaching an oversubscription rate of 15.5x.
Multi-year partnership lands as Prenetics' IM8 raises full-year 2026 revenue guidance to $190 million to $210 million following nearly 6x year-over-year growth in Q1 2026 Shetty is IM8's first global

Prenetics Global Q1 Earnings Call Highlights

03:07pm, Thursday, 14'th May 2026
Prenetics Global NASDAQ: PRE said its first-quarter results reflected the company's shift away from diagnostics and genome testing toward a subscription-driven consumer health model anchored by its IM
~ Two-decade veteran of premium consumer health, nutrition, and direct-to-consumer brands joins IM8 to support its rapid global expansion
Prenetics records Q1 2026 revenue of  $36.0 million with IM8 revenue of $33.8 million , up 23.1% from IM8 revenue of $27.4 million in Q4 2025 Raises full-year 2026 IM8 revenue guidance to $190 millio
NEW YORK, May 08, 2026 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) ("Prenetics" or the "Company"), the parent company of IM8, the premium health and longevity brand co-founded with Davi
NEW YORK and MIAMI, May 07, 2026 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) (“Prenetics” or the “Company”), the parent company of IM8, the premium health and longevity brand co
TSXV: ITR; NYSE American: ITRG www.integraresources.com VANCOUVER, BC, April 29, 2026 /PRNewswire/ - Integra Resources Corp. ("Integra" or the "Company") (TSXV: ITR) (NYSE American: ITRG) is pleased
I am strongly bullish on Prenetics Global Limited, driven by the IM8 product and a successful shift to quarterly subscriptions doubling customer value. PRE's revenue is projected to grow 105.7% YoY in
Prenetics Global Limited (PRE) remains a buy, with a 15% near-term and 60% 24-month upside potential based on robust revenue growth projections. PRE's strategic focus on IM8, divestiture of non-core a
Prenetics Global (NASDAQ: PRE - Get Free Report) and GH Research (NASDAQ: GHRS - Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two busi
NEW YORK, March 24, 2026 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) ("Prenetics" or the "Company"), a leading consumer health sciences company and parent of the IM8 premium health and
Prenetics Global (NASDAQ: PRE) CEO and co-founder Danny Yeung told investors the company delivered what he described as a "breakout growth story" in 2025, driven by the rapid expansion of its IM8 dire
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE